Table 4 Association of the metabolic and vascular markers expression with the clinicopathological variables in SCC samples

0.901

0.029

0.024

0.711

0.208

14

6 (42.9)

14

5 (35.7)

14

0 (0.0)

15

12 (80.0)

14

9 (64.3)

20

9 (45.0)

19

14 (73.7)

18

6 (33.3)

22

16 (72.7)

19

8 (42.1)

0.644

0.600

1.000

0.624

1.000

11

4 (36.4)

11

7 (63.6)

11

2 (18.2)

14

10 (71.4)

11

4 (36.4)

6

3 (50.0)

6

5 (83.3)

6

1 (16.7)

7

6 (85.7)

6

2 (33.3)

0.634

0.138

1.000

0.307

0.335

29

12 (41.4)

28

18 (64.3)

27

5 (18.5)

32

23 (71.9)

28

13 (46.4)

5

3 (60.0)

5

1 (20.0)

5

1 (20.0)

5

5 (100.0)

5

4 (80.0)

VEGF-A

VEGF-C

VEGFR-1

VEGFR-2

VEGFR-3

n

Positive (%)

p

n

Positive (%)

p

n

Positive (%)

p

n

Positive (%)

p

n

Positive (%)

p

0.270

1.000

0.681

1.000

0.455

13

11 (84.6)

14

13 (92.9)

14

2 (14.3)

14

11 (78.6)

14

3 (21.4)

23

15 (64.2)

22

20 (90.9)

22

5 (22.7)

22

18 (81.8)

19

7 (36.8)

0.624

1.000

0.517

0.557

0.600

14

10 (71.4)

13

12 (92.3)

13

3 (23.1)

13

11 (84.6)

11

4 (36.4)

7

6 (85.7)

6

6 (100.0)

6

0 (0.0)

6

4 (66.7)

6

1 (16.7)

0.603

0.370

0.559

0.244

0.627

31

23 (74.2)

31

29 (93.5)

31

7 (22.6)

31

26 (83.9)

28

8 (28.6)

5

3 (60.0)

5

4 (80.0)

5

0 (0.0)

5

3 (60.0)

5

2 (40.0)